Evidence map›Paper›PMID 41125830›Full record

ArticleScientific reports2025

Characterization of a phosphoinositide-binding protein containing a PHOX homology domain in the malaria parasite Plasmodium falciparum.

Stéphanie Roucheray, Dominik Stastny, Harpreet Kaur, Dana Tahotna, Joel B Dacks, Peter Griac, Dave Richard

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stéphanie RoucherayDepartment of Microbiology-Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Québec, QC, Canada.
Dominik StastnyInstitute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dubravska Cesta 9, 840 05, Bratislava, Slovakia.
Harpreet KaurDivision of Infectious Diseases, Department of Medicine, and Department of Biological Sciences, University of Alberta, 1-124 Clinical Sciences Building, 11350-83 Avenue, Edmonton, T6G 2G3, Canada.
Dana TahotnaInstitute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dubravska Cesta 9, 840 05, Bratislava, Slovakia.
Joel B DacksDivision of Infectious Diseases, Department of Medicine, and Department of Biological Sciences, University of Alberta, 1-124 Clinical Sciences Building, 11350-83 Avenue, Edmonton, T6G 2G3, Canada.
Peter GriacInstitute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dubravska Cesta 9, 840 05, Bratislava, Slovakia.
Dave RichardDepartment of Microbiology-Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Québec, QC, Canada. dave.richard@crchudequebec.ulaval.ca.

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
CIHR 406675Natural Sciences and Engineering Research Council of Canada RES0043758, and RES0046091NIGMS NIH HHS R01 GM129325Slovak Academy of Sciences VEGA 2/0047/23
6 · The paper itself

Abstract

Phosphoinositides (PIPs), are key regulators of membrane identity and vesicular trafficking. By dynamically shaping the lipid composition of intracellular membranes, PIPs help ensure the specificity of cargo delivery. In apicomplexan parasites such as Plasmodium falciparum, the biogenesis of the specialized secretory organelles involved in erythrocyte invasion (named rhoptries, micronemes, and dense granules), remains poorly understood, particularly regarding how proteins are sorted and specifically targeted to their respective destinations. Our hypothesis is that PIPs might play a role in this process. We here present our characterization of the P. falciparum protein Pf3D7_0704400, a putative PIP-binding protein containing a PX domain. We named this protein PfPX2, following the previously characterized PX domain-containing protein PfPX1. In silico structural analysis revealed that the PfPX2 PX domain contains both canonical and non-canonical PIP-binding motifs and a positively charged binding pocket. Lipid binding assays showed that the PfPX2 PX domain can bind all species of PIPs with a preference for PI3P, PI5P and PI(3,5)P2. Immunofluorescence assays demonstrated that PfPX2 localized to the Golgi apparatus and the micronemes in developing schizonts. Moreover, proximity labelling enabled the identification of protein such as PfSortilin, the clathrin heavy chain and PfDyn1 as potential interactors of PfPX2. Globally, these data suggest that PfPX2 is a PIP-binding protein potentially implicated in vesicular trafficking between the Golgi apparatus and the micronemes. Our bioinformatics analyses identified PX2 orthologues across apicomplexans and indeed other alveolates, raising the possibility that this protein plays a role in a broad range of medically, agriculturally, and environmentally relevant organisms.

Indexed as

PhosphatidylinositolsPlasmodium falciparumProtozoan ProteinsAmino Acid SequenceBinding SitesGolgi ApparatusHumansMalaria, FalciparumProtein BindingProtein DomainsPhosphatidylinositolsProtozoan ProteinsGolgiMalariaPhosphoinositidesProtein traffickingPX domain

Identifiers

PMID41125830
PMCPMC12546714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.